Click the icons below to search through Pioneer’s reports and documents.
|Version||1 Previous versions
|Date added||February 10, 2020|
|Category||Life Sciences, PioneerLegal, Policy Briefs|
Date: February 10, 2020
Authors: Jim McKenna and William Smith
This new report outlines several potential legal violations and negative implications for disabled individuals related to the adoption of the quality adjusted life years (QALY) approach to drug value assessment, used most prominently by the Institute for Clinical and Economic Review (ICER).